Skip to content
About
Science
Pipeline
Investors & Media
FAQs
Contact
Investors & Media
All
Articles
Press Releases
Publications & Presentations
All
Articles
Press Releases
Publications & Presentations
Publications & Presentations
First-in-Human Clinical Trial of Autologous Human B Cells Engineered to Express Human Iduronidase in Subjects with MPS I
May 13, 2026
ASGCT – American Society of Gene & Cell Therapy
Publications & Presentations
Advancing Pediatric CGT Clinical Trials: Scientific, Ethical, Regulatory & Practical Considerations
April 14, 2026
FDA & ARM (Alliance for Regenerative Medicine)
Publications & Presentations
Translational data from the first-in-human clinical trial of autologous human B cells engineered to express human iduronidase in subjects with MPS I
April 9, 2026
WORLDSymposium
Publications & Presentations
Engineering B Cells With Immusoft’s Sean Ainsworth
December 9, 2025
Business of Biotech
Publications & Presentations
Fighting mucopolysaccharidosis type I, a rare disease, by reprogramming B-cells
May 16, 2025
Beyond Biotech
Publications & Presentations
Safety and Initial Activity of Autologous Human B Cells Genetically Engineered to Express Human Iduronidase Using the Sleeping Beauty Transposon System: Results from a First-in-Human Clinical Trial in Subjects with MPS I
February 7, 2025
WORLDSymposium
Publications & Presentations
RARECast: Engineering B cells to Produce Therapeutic Proteins
December 19, 2024
Global Genes
Publications & Presentations
MPS I Clinical Update and Outreach Webinar: Highlights
December 17, 2024
Immusoft
Publications & Presentations
MPS I Clinical Update and Outreach Webinar
October 24, 2024
Immusoft
